irinotecan has been researched along with artesunic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Du, Y; He, W; Li, X; Wang, J; Wang, T | 1 |
| Dai, QL; Jia, HJ; Rui Bai, S; Wang, XB; Xia, J; Yue He, S; Zhou, M | 1 |
2 other study(ies) available for irinotecan and artesunic acid
| Article | Year |
|---|---|
Dimeric Artesunate-Phosphatidylcholine-Based Liposomes for Irinotecan Delivery as a Combination Therapy Approach.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artesunate; Cell Line, Tumor; Drug Combinations; Drug Delivery Systems; Female; Irinotecan; Liposomes; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Phosphatidylcholines | 2021 |
Artesunate ameliorates irinotecan-induced intestinal injury by suppressing cellular senescence and significantly enhances anti-tumor activity.
Topics: Animals; Artesunate; Camptothecin; Cellular Senescence; Humans; Intestinal Diseases; Irinotecan; Mice; Neoplasms; TOR Serine-Threonine Kinases | 2023 |